456 related articles for article (PubMed ID: 37143147)
1. Mesenchymal stromal cell-derived secretome-based therapy for neurodegenerative diseases: overview of clinical trials.
Ghasemi M; Roshandel E; Mohammadian M; Farhadihosseinabadi B; Akbarzadehlaleh P; Shamsasenjan K
Stem Cell Res Ther; 2023 May; 14(1):122. PubMed ID: 37143147
[TBL] [Abstract][Full Text] [Related]
2. Insights into the Effects of Mesenchymal Stem Cell-Derived Secretome in Parkinson's Disease.
d'Angelo M; Cimini A; Castelli V
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32718092
[TBL] [Abstract][Full Text] [Related]
3. Molecular Mechanisms Responsible for Therapeutic Potential of Mesenchymal Stem Cell-Derived Secretome.
Harrell CR; Fellabaum C; Jovicic N; Djonov V; Arsenijevic N; Volarevic V
Cells; 2019 May; 8(5):. PubMed ID: 31100966
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotection by Human Dental Pulp Mesenchymal Stem Cells: From Billions to Nano.
Venugopal C; K S; Rai KS; Pinnelli VB; Kutty BM; Dhanushkodi A
Curr Gene Ther; 2018; 18(5):307-323. PubMed ID: 30209999
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal Stem Cell-Derived Secretome: A Potential Therapeutic Option for Autoimmune and Immune-Mediated Inflammatory Diseases.
Műzes G; Sipos F
Cells; 2022 Jul; 11(15):. PubMed ID: 35892597
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal Stromal Cell Secretome: Influencing Therapeutic Potential by Cellular Pre-conditioning.
Ferreira JR; Teixeira GQ; Santos SG; Barbosa MA; Almeida-Porada G; Gonçalves RM
Front Immunol; 2018; 9():2837. PubMed ID: 30564236
[TBL] [Abstract][Full Text] [Related]
7. The effect of Trimetazidine and Diazoxide on immunomodulatory activity of human embryonic stem cell-derived mesenchymal stem cell secretome.
Jahandideh S; Maghsood F; Ghahhari NM; Lotfinia M; Mohammadi M; Johari B; Kadivar M
Tissue Cell; 2017 Oct; 49(5):597-602. PubMed ID: 28843336
[TBL] [Abstract][Full Text] [Related]
8. The Therapeutic Potential of Mesenchymal Stem Cell-Derived Exosomes in Treatment of Neurodegenerative Diseases.
Gorabi AM; Kiaie N; Barreto GE; Read MI; Tafti HA; Sahebkar A
Mol Neurobiol; 2019 Dec; 56(12):8157-8167. PubMed ID: 31197655
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal Stromal Cells (MSCs): A Promising Tool for Cell-Based Angiogenic Therapy.
Ulpiano C; da Silva CL; Monteiro GA
Curr Gene Ther; 2021; 21(5):382-405. PubMed ID: 34533444
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal Stromal Cell Secretome: Immunomodulation, Tissue Repair and Effects on Neurodegenerative Conditions.
Zriek F; Di Battista JA; Alaaeddine N
Curr Stem Cell Res Ther; 2021; 16(6):656-669. PubMed ID: 33530914
[TBL] [Abstract][Full Text] [Related]
11. Advances in mesenchymal stem cell conditioned medium-mediated periodontal tissue regeneration.
Lin H; Chen H; Zhao X; Chen Z; Zhang P; Tian Y; Wang Y; Ding T; Wang L; Shen Y
J Transl Med; 2021 Nov; 19(1):456. PubMed ID: 34736500
[TBL] [Abstract][Full Text] [Related]
12. Priming mesenchymal stromal cells with neurotrophic factors boosts the neuro-regenerative potential of their secretome.
Teli P; Nachanekar A; Kale V; Vaidya A
Regen Med; 2023 Apr; 18(4):329-346. PubMed ID: 36950925
[TBL] [Abstract][Full Text] [Related]
13. Towards the Standardization of Mesenchymal Stem Cell Secretome-Derived Product Manufacturing for Tissue Regeneration.
Chouaib B; Haack-Sørensen M; Chaubron F; Cuisinier F; Collart-Dutilleul PY
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628774
[TBL] [Abstract][Full Text] [Related]
14. Potential of mesenchymal stem cell-derived conditioned medium/secretome as a therapeutic option for ocular diseases.
Bouche Djatche WH; Zhu H; Ma W; Li Y; Li Z; Zhao H; Liu Z; Qiao H
Regen Med; 2023 Oct; 18(10):795-807. PubMed ID: 37702008
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow- or adipose-mesenchymal stromal cell secretome preserves myocardial transcriptome profile and ameliorates cardiac damage following ex vivo cold storage.
Scott SR; March KL; Wang IW; Singh K; Liu J; Turrentine M; Sen CK; Wang M
J Mol Cell Cardiol; 2022 Mar; 164():1-12. PubMed ID: 34774548
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic Effects of Physical Exercise and the Mesenchymal Stem Cell Secretome by Modulating Neuroinflammatory Response in Multiple Sclerosis.
González LM; Ospina LN; Sperling LE; Chaparro O; Cucarián JD
Curr Stem Cell Res Ther; 2022; 17(7):621-632. PubMed ID: 34886779
[TBL] [Abstract][Full Text] [Related]
17. Clinical potential and current progress of mesenchymal stem cells for Parkinson's disease: a systematic review.
Chen Y; Shen J; Ke K; Gu X
Neurol Sci; 2020 May; 41(5):1051-1061. PubMed ID: 31919699
[TBL] [Abstract][Full Text] [Related]
18. Insights of Extracellular Vesicles of Mesenchymal Stem Cells: a Prospective Cell-Free Regenerative Medicine for Neurodegenerative Disorders.
Vatsa P; Negi R; Ansari UA; Khanna VK; Pant AB
Mol Neurobiol; 2022 Jan; 59(1):459-474. PubMed ID: 34714469
[TBL] [Abstract][Full Text] [Related]
19. The secretome of mesenchymal stem cells and oxidative stress: challenges and opportunities in cell-free regenerative medicine.
Rahimi B; Panahi M; Saraygord-Afshari N; Taheri N; Bilici M; Jafari D; Alizadeh E
Mol Biol Rep; 2021 Jul; 48(7):5607-5619. PubMed ID: 34191238
[TBL] [Abstract][Full Text] [Related]
20. Secretome released from hydrogel-embedded adipose mesenchymal stem cells protects against the Parkinson's disease related toxin 6-hydroxydopamine.
Chierchia A; Chirico N; Boeri L; Raimondi I; Riva GA; Raimondi MT; Tunesi M; Giordano C; Forloni G; Albani D
Eur J Pharm Biopharm; 2017 Dec; 121():113-120. PubMed ID: 28965958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
